A meta-analysis of pain response in the treatment of fibromyalgia

Pain Practice

Volumn 11, Issue 6, 2011, Pages 516-527

  Roskell, Neil S ^a   Beard, Stephen M ^a   Zhao, Yang ^b   Le, Trong Kim ^b  

^a RTI HEALTH SOLUTIONS   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Fibromyalgia; Meta analysis; Pain; Systematic review

Indexed keywords

AMITRIPTYLINE; CYCLOBENZAPRINE; DULOXETINE; FLUOXETINE; GABAPENTIN; MILNACIPRAN; PARACETAMOL PLUS TRAMADOL; PLACEBO; PRAMIPEXOLE; PREGABALIN;

ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EVIDENCE BASED PRACTICE; FIBROMYALGIA; HUMAN; META ANALYSIS; PAIN; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW;

EID: 80655149556     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2010.00441.x     Document Type: Article

References (34)

1. Bennett RM. Fibromyalgia and the disability dilemma: a new era in understanding a complex, multidimensional pain syndrome. Arthritis Rheum. 1996;39:1627-1634.
2. MacFarlane GF. Fibromyalgia and chronic widespread pain. In: Crombie IK, Croft PR, Linto SJ, LeResche L, Von Korff M, eds. Epidemiology of Pain. Seattle, WA: International Association for the Study of Pain; 1999:113-123.
3. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38:19-28.
4. Wallace DJ, Wallace JB. All About Fibromyalgia: A Guide for Patients and Their Families. Oxford: Oxford University Press; 2002.
5. Wolfe F. Fibromyalgia: the clinical syndrome. Rheum Dis Clin North Am. 1989;15:1-18.
6. Buckhardt CS, Goldenberg D, Crofford L, etal. Guideline for the Management of Fibromyalgia Syndrome Pain in Adults and Children. Glenview, IL: American Pain Society; 2005. [WWW document]. URL [accessed on May 24, 2010.
7. Carville SF, Arendt-Nielsen S, Bliddal H, etal. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008;67:536-541.
8. Klement A, Häuser W, Brückle W, etal. Principles of treatment, coordination of medical care and patient education in fibromyalgia syndrome and chronic widespread pain [article in German]. Schmerz. 2008;22:283-294.
9. Häuser W, Thieme K, Turk DC. Guidelines on the management of fibromyalgia syndrome-a systematic review. Eur J Pain. 2010;14:5-10.
10. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997;50:683-691.
11. Song F, Altman DG, Glenny AM, Deeks JJ. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ. 2003;326:472.
12. Wells GA, Sultan SA, Chen L, Khan M, Coyle D. Indirect Evidence: Indirect Treatment Comparisons in Meta-Analysis. Ottawa, Canada: Canadian Agency for Drugs and Technologies in Health; 2009.
13. Whitehead A. Meta-Analysis of Controlled Clinical Trials. Chichester, West Sussex, England, U.K.: John Wiley & Sons, Ltd.; 2002.
14. Arnold LM, Rosen A, Pritchett YL, etal. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005;119:5-15.
15. Russell IJ, Mease PJ, Smith TR, etal. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain. 2008;136:432-444.
16. Arnold LM, Hess EV, Hudson JI, Welge JA, Berno SE, Keck PE. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med. 2002;112:191-197.
17. Goldenberg D, Mayskiy M, Mossey C, Ruthazer R, Schmid C. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum. 1996;39:1852-1859.
18. Wolfe F, Cathey MA, Hawley DJ. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol. 1994;23:255-259.
19. Arnold LM, Goldenberg DL, Stanford SB, etal. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum. 2007;56:1336-1344.
20. Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther. 2008;30:1988-2004. Erratum in: Clin Ther. 2009;31:1617; Clin Ther. 2009;31:446.
21. Mease PJ, Clauw DJ, Gendreau RM, etal. The efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial. J Rheumatol. 2009;36:398-409.
22. Gendreau RM, Thorn MD, Gendreau JF, etal. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol. 2005;32:1975-1985.
23. Holman AJ, Myers RR. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum. 2005;52:2495-2505.
24. Arnold LM, Russell IJ, Diri EW, etal. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain. 2008;9:792-805.
25. Crofford LJ, Rowbotham MC, Mease PJ, etal. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005;52:1264-1273.
26. Mease PJ, Russell IJ, Arnold LM, etal. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol. 2008;35:502-514.
27. Carette S, McCain GA, Bell DA, Fam AG. Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study. Arthritis Rheum. 1986;29:655-659.
28. Carette S, Oakson G, Guimont C, Steriade M. Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia. Arthritis Rheum. 1995;38:1211-1217.
29. Heymann RE, Helfenstein M, Feldman D. A double-blind, randomized, controlled study of amitriptyline, nortriptyline and placebo in patients with fibromyalgia. An analysis of outcome measures. Clin Exp Rheumatol. 2001;19:697-702.
30. Scudds RA, McCain GA, Rollman GB, Harth M. Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline. J Rheumatol. 1989;19:98-103.
31. Carette S, Bell MJ, Reynolds WJ, etal. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum. 1994;37:32-40.
32. Bennett RM, Gatter RA, Campbell SM, Andrews RP, Clark SR, Scarola JA. A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study. Arthritis Rheum. 1988;31:1535-1542.
33. Quimby LG, Gratwick GM, Whitney CD, Block SR. A randomized trial of cyclobenzaprine for the treatment of fibromyalgia. J Rheumatol. 1989;19:140-143.
34. Bennett RM, Kamin M, Karim R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med. 2003;114:537-545.